MediWound Statistics
Total Valuation
MediWound has a market cap or net worth of $195.40 million. The enterprise value is $159.17 million.
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025, before market open.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MediWound has 10.81 million shares outstanding. The number of shares has increased by 10.50% in one year.
| Current Share Class | 10.81M |
| Shares Outstanding | 10.81M |
| Shares Change (YoY) | +10.50% |
| Shares Change (QoQ) | +2.66% |
| Owned by Insiders (%) | 1.75% |
| Owned by Institutions (%) | 43.28% |
| Float | 7.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.90 |
| Forward PS | 7.51 |
| PB Ratio | 6.26 |
| P/TBV Ratio | 6.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.97 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.88 |
Financial Efficiency
Return on equity (ROE) is -96.33% and return on invested capital (ROIC) is -31.74%.
| Return on Equity (ROE) | -96.33% |
| Return on Assets (ROA) | -17.33% |
| Return on Invested Capital (ROIC) | -31.74% |
| Return on Capital Employed (ROCE) | -41.32% |
| Revenue Per Employee | $182,180 |
| Profits Per Employee | -$272,288 |
| Employee Count | 111 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 6.35 |
Taxes
In the past 12 months, MediWound has paid $61,000 in taxes.
| Income Tax | 61,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.27% in the last 52 weeks. The beta is 0.50, so MediWound's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +2.27% |
| 50-Day Moving Average | 17.02 |
| 200-Day Moving Average | 17.69 |
| Relative Strength Index (RSI) | 60.27 |
| Average Volume (20 Days) | 78,816 |
Short Selling Information
| Short Interest | 1.04M |
| Short Previous Month | 1.01M |
| Short % of Shares Out | 11.35% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.66 |
Income Statement
In the last 12 months, MediWound had revenue of $20.22 million and -$30.22 million in losses. Loss per share was -$3.03.
| Revenue | 20.22M |
| Gross Profit | 2.63M |
| Operating Income | -19.40M |
| Pretax Income | -12.55M |
| Net Income | -30.22M |
| EBITDA | -18.58M |
| EBIT | -19.40M |
| Loss Per Share | -$3.03 |
Full Income StatementBalance Sheet
The company has $43.16 million in cash and $6.93 million in debt, giving a net cash position of $36.23 million or $3.35 per share.
| Cash & Cash Equivalents | 43.16M |
| Total Debt | 6.93M |
| Net Cash | 36.23M |
| Net Cash Per Share | $3.35 |
| Equity (Book Value) | 31.15M |
| Book Value Per Share | 2.89 |
| Working Capital | 25.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.62 million and capital expenditures -$6.27 million, giving a free cash flow of -$19.90 million.
| Operating Cash Flow | -13.62M |
| Capital Expenditures | -6.27M |
| Free Cash Flow | -19.90M |
| FCF Per Share | -$1.84 |
Full Cash Flow StatementMargins
Gross margin is 13.03%, with operating and profit margins of -95.94% and -149.46%.
| Gross Margin | 13.03% |
| Operating Margin | -95.94% |
| Pretax Margin | -149.16% |
| Profit Margin | -149.46% |
| EBITDA Margin | -91.89% |
| EBIT Margin | -95.94% |
| FCF Margin | n/a |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.50% |
| Shareholder Yield | n/a |
| Earnings Yield | -15.47% |
| FCF Yield | -10.18% |
Analyst Forecast
The average price target for MediWound is $32.00, which is 77.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.00 |
| Price Target Difference | 77.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 46.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 20, 2022. It was a reverse split with a ratio of 0.1428571:1.
| Last Split Date | Dec 20, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1428571:1 |
Scores
MediWound has an Altman Z-Score of -1.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.78 |
| Piotroski F-Score | 1 |